CRISPR THERAPTC (CRSP) Given Average Recommendation of “Strong Buy” by Brokerages – The Cerbat Gem
|
CRISPR THERAPTC (CRSP) Given Average Recommendation of “Strong Buy” by Brokerages
The Cerbat Gem CRISPR THERAPTC logo Shares of CRISPR THERAPTC (NASDAQ:CRSP) have been assigned a consensus broker rating score of 1.00 (Strong Buy) from the two analysts that cover the company, Zacks Investment Research reports. Two investment analysts … |
